Open Forum Infectious Diseases
Scope & Guideline
Pioneering research for a healthier tomorrow.
Introduction
Aims and Scopes
- Epidemiology and Surveillance:
The journal frequently publishes research on the epidemiological trends of infectious diseases, including outbreaks, prevalence studies, and surveillance methodologies. This focus helps in understanding disease patterns and informing public health interventions. - Antimicrobial Resistance:
A significant portion of the research addresses issues related to antimicrobial resistance, including resistance patterns, mechanisms, and the impact on treatment outcomes. This area is crucial for developing strategies to combat resistant infections. - Clinical Management and Treatment Strategies:
The journal emphasizes clinical studies that evaluate the efficacy and safety of various treatment modalities for infectious diseases, including antiviral, antibacterial, and antifungal therapies. - Vaccination and Preventive Strategies:
Research on vaccination effectiveness, vaccine hesitancy, and strategies for public health vaccination campaigns is a core focus, particularly in the context of emerging infectious diseases like COVID-19. - Public Health and Policy Implications:
The journal explores the intersection of infectious diseases with public health policies, health equity, and the socio-economic factors influencing disease spread and management. - Innovative Diagnostic Techniques:
There is a strong emphasis on the development and evaluation of new diagnostic tools and technologies for infectious diseases, including molecular diagnostics and rapid testing methods.
Trending and Emerging
- COVID-19 Research:
There is a robust increase in publications related to COVID-19, including studies on its epidemiology, treatment, vaccination, and long-term sequelae. This trend is likely driven by the ongoing relevance of the pandemic. - Mental Health and Infectious Diseases:
Emerging research is beginning to explore the intersection of mental health and infectious diseases, particularly in the context of COVID-19 and its psychological impacts. - Telemedicine and Remote Care:
The adoption of telemedicine for infectious disease management has surged, with more studies evaluating its effectiveness and patient acceptance, especially during and after the COVID-19 pandemic. - Social Determinants of Health:
Research focusing on social determinants of health, particularly how they affect the prevalence and management of infectious diseases, is gaining prominence as public health initiatives aim for more equitable health outcomes. - Long COVID and Post-Acute Sequelae of SARS-CoV-2 Infection:
There is a growing body of research dedicated to understanding the long-term effects of COVID-19, termed Long COVID, which is becoming a significant area of interest within the journal.
Declining or Waning
- Traditional Infectious Disease Surveillance:
The focus on traditional methods of infectious disease surveillance seems to be waning, as newer, more advanced techniques such as molecular surveillance and real-time data analytics gain traction. - Single-Pathogen Studies:
Research that concentrates solely on single pathogens is becoming less common, with a noticeable trend towards multispecies studies and the exploration of polymicrobial infections. - Antibiotic Stewardship Programs:
While still relevant, the volume of publications specifically dedicated to antibiotic stewardship programs has decreased, possibly due to the establishment of these programs as standard practice in many clinical settings. - Chronic Infectious Diseases Research:
There seems to be a reduced emphasis on chronic infectious diseases, such as long-term tuberculosis management, as the journal increasingly prioritizes acute infectious diseases and emerging threats.
Similar Journals
Infectious Diseases
Innovative Research for a Healthier TomorrowInfectious Diseases, published by TAYLOR & FRANCIS LTD, is a leading academic journal dedicated to advancing research in the field of infectious diseases and microbiology. With an impressive impact factor and categorized in Q1 in multiple areas including Immunology and Microbiology, this journal serves as a critical platform for researchers, practitioners, and students to disseminate their findings and stay abreast of current advancements. The journal is recognized for its rigorous peer-review process and aims to foster innovation and collaboration across disciplines from 2015 to 2024. It boasts a robust Scopus ranking, positioning it favorably among the top-tier of journals in the relevant fields, making it an essential resource for anyone involved in infectious disease research. Access options are available, ensuring that the latest research is accessible to a global audience, thus emphasizing the journal's commitment to promoting knowledge and understanding in the ever-evolving landscape of infectious diseases.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
Connecting researchers to advance immunological science.Welcome to the Journal of Microbiology Immunology and Infection, a premier academic publication established in 1998 and now proudly owned by Elsevier Taiwan. As an Open Access journal since 2016, it provides unrestricted access to groundbreaking research in the fields of immunology, microbiology, and infectious diseases, making it an essential resource for researchers, practitioners, and students alike. The journal holds impressive rankings, including Q1 status in categories such as Infectious Diseases and Microbiology (medical), and a notable 92nd percentile in its Scopus ranking for Medicine - Infectious Diseases. With a dedicated focus on advancing knowledge and fostering collaboration within the scientific community, the Journal of Microbiology Immunology and Infection is committed to publishing high-impact research that significantly influences practice and policy in healthcare and life sciences. The journal is also recognized for its contribution to the ongoing dialogue surrounding contemporary issues in immunology and infection, positioning it as a vital platform for scholarly exchange and innovation.
INFECTION
Advancing the Science of Infectious DiseasesINFECTION is a prestigious journal, published by Springer Heidelberg, that serves as a leading platform for the dissemination of critical research in the fields of Infectious Diseases, Microbiology, and Medicine. With an impressive Q1 ranking in multiple categories such as Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology, the journal is recognized for its high-quality content and impactful contributions to the scientific community, as evidenced by its Scopus rankings placing it in the top 10th percentiles. Since its inception in 1973, and projected to continue until 2024, INFECTION has established itself as a vital resource for researchers, healthcare professionals, and students keen to explore the latest findings and advancements in infectious diseases. The journal provides a rigorous peer-review process, ensuring that only high-quality studies are published, making it an essential read for those seeking to deepen their understanding and stay abreast of the rapidly evolving landscape in infection research.
Southern African Journal of Infectious Diseases
Advancing research for a healthier Southern Africa.Southern African Journal of Infectious Diseases is a pivotal platform for the dissemination and advancement of research in the field of infectious diseases, with a particular focus on issues significant to the Southern African region. Published by AOSIS, this Open Access journal has been committed to providing accessible scholarly content since 2016, enabling researchers and practitioners to stay updated with the latest developments in infectious disease epidemiology, prevention, and management. With the ISSN 2312-0053 and E-ISSN 2313-1810, the journal invites submissions that explore diverse topics, including but not limited to clinical studies, public health policies, and innovative treatment methodologies. The Southern African Journal of Infectious Diseases is an essential resource for academics, professionals, and students dedicated to combating infectious diseases and improving health outcomes in the region, fostering a collaborative approach to research and knowledge sharing.
JOURNAL OF CLINICAL MICROBIOLOGY
Transforming Knowledge into Clinical PracticeJOURNAL OF CLINICAL MICROBIOLOGY, published by the American Society for Microbiology, stands as a premier resource for researchers and professionals in the field of medical microbiology. With an illustrious history dating back to 1975, this journal has consistently provided high-impact research, reflecting its status in the Q1 category among microbiology (medical) journals, and an impressive Scopus rank of 14 out of 140, placing it in the 90th percentile. The journal's commitment to unveiling foundational and innovative studies greatly contributes to understanding human health challenges posed by microbial pathogens. Researchers can expect rigorous peer-reviewed articles that cover a spectrum of topics, from diagnostic methods to clinical epidemiology, fostering a deeper understanding of microbiology's role in healthcare. While this journal does not offer open access options, its substantial impact factor underscores its relevance in shaping the conversation in clinical microbiology. The JOURNAL OF CLINICAL MICROBIOLOGY is indispensable for anyone dedicated to advancing their knowledge and practical skills in microbiology.
IJID Regions
Illuminating contemporary health challenges with innovative research.IJID Regions is a pioneering open access journal published by Elsevier, focusing on the critical fields of epidemiology, infectious diseases, and public health. Established in 2021, the journal aims to provide a platform for disseminating high-quality, innovative research that addresses pressing health issues and informs evidence-based practices in communities around the globe. With its impact factors reflecting a Tier Q2 and Q3 ranking in various medical subcategories on the Scopus platform, IJID Regions is positioned as a valuable resource for researchers, health professionals, and policy-makers striving to enhance public health outcomes. This journal not only champions open access since its inception, promoting the free flow of information, but also welcomes contributions that shed light on contemporary challenges in environmental and occupational health. Its commitment to fostering dialogue and collaboration in the health sciences is paramount, making it an essential read for those engaged in advancing public health knowledge and initiatives.
Indian Journal of Medical Microbiology
Pioneering Research in Medical Microbiology Since 1986Indian Journal of Medical Microbiology, published by Elsevier, is a pivotal peer-reviewed journal dedicated to the field of medical microbiology, providing a vital platform for research and scholarship since its inception in 1986. With an Open Access model established in 2001, it ensures the dissemination of scientific knowledge to a global audience, enhancing accessibility for researchers, professionals, and students alike. The journal's scope spans critical areas including immunology, infectious diseases, and microbiology, with an impressive trajectory marked by converged years of publication allowing for a comprehensive exploration of evolving scientific trends. As of 2023, the journal holds a Q3 ranking in Infectious Diseases and Microbiology (medical) and a Q4 ranking in Immunology and Microbiology categories, reflecting its significant yet growing impact in the field. Researchers seeking to contribute to or stay updated on the latest advancements in medical microbiology will find the Indian Journal of Medical Microbiology a valuable resource, as it consistently bridges the gap between emerging science and clinical application.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Empowering public health through open access research.INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, published by ELSEVIER SCI LTD, stands as a leading platform in the realm of infectious diseases, contributing significantly to the global understanding of this critical field. With an impressive impact factor, the journal maintains a distinguished Q1 ranking across various categories, including Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology, demonstrating its high relevance and influence among contemporary research. Since its inception in 1996, it has embraced an Open Access model, allowing for wider dissemination of essential research findings that can inform public health policies and clinical practices. With a commitment to advancing scientific knowledge, this journal is not only a vital resource for researchers and professionals but also serves as an invaluable educational tool for students interested in the complexities of infectious diseases and their management. For those looking to stay at the forefront of research and innovation in this field, the INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES is an indispensable resource.
Infectious Diseases Now
Empowering healthcare through open access research.Infectious Diseases Now is a premier academic journal dedicated to the evolving field of infectious diseases, published by Elsevier France - Éditions Scientifiques Médicales Elsevier. With an ISSN of 2666-9927 and an E-ISSN of 2666-9919, this journal stands at the forefront of disseminating critical research and clinical insights from 2021 to 2024. The journal's commitment to open access means that groundbreaking studies are readily available to researchers, healthcare professionals, and students, fostering a collaborative approach to tackling global health challenges. As evidenced by its Q2 quartile ranking in the 2023 Scopus category of Infectious Diseases, and its impressive position within the top 25% of its field, Infectious Diseases Now serves as an essential resource for those involved in the study and management of infectious diseases. By publishing high-quality research, case studies, and reviews, the journal plays a pivotal role in advancing knowledge and improving patient care in this vital area of medicine.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Illuminating the complexities of microbiology and its clinical applications.ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA is a prominent journal dedicated to the fields of infectious diseases and clinical microbiology, published by EDICIONES DOYMA S A in Spain. With an ISSN of 0213-005X and an e-ISSN of 1578-1852, the journal has been a cornerstone of research and scholarly communication since its inception in 1989. As of 2023, it holds a Q3 category ranking in Infectious Diseases, highlighting its significance in the field, alongside a Q4 ranking in the related area of Microbiology. Although the journal is not open access, it remains an essential resource for professionals, researchers, and students aiming to stay informed on advancements and studies that impact clinical practices in infectious diseases. With Scopus ranks indicating a percentile ranking in the 20th to 34th range across various sub-disciplines, ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA continually contributes to the dialogue and development of science, fostering a deeper understanding of complex microbial interactions and disease mechanisms.